Vtv Therapeutics Inc (VTVT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Vtv Therapeutics Inc   (NASDAQ: VTVT)


Vtv Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vtv Therapeutics Inc's ROI in the second quarter of 2026?
Vtv Therapeutics Inc recorded a cumulative net loss of $-6 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -7.42%.

Within the Healthcare sector 223 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2551 to 2611.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 177.63 % 94.17 % 31.63 % 29.91 % 25.64 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 81 92 83 89 21
Return On Investment (TTM) -7.42 % -1.02 % -55.98 % -65.24 % -76.83 %
VTVT's Overall Ranking # 2611 # 2551 # 2603 # 2779 # 3036
Seq. Investment Change TTM 20.95 % 28.48 % 27.64 % 39.97 % -15.41 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -6 -1 -31 -28 -24




Return On Investment VTVT's Ranking
Within: No.
Industry # 80
Sector # 224
Overall # 2611

Return On Investment Statistics
High Average Low
-0.85 %
-140.92 %
-1059.55 %
(Mar 31 2026)   (Dec 31 2020)







Financial Statements
Vtv Therapeutics Inc's II. Quarter Investments $ 81 Millions VTVT's Balance sheet
Vtv Therapeutics Inc's II. Quarter Income $ -13 Millions Quarterly VTVT's Income Statement
VTVT's Income by Division See VTVT's Income by Division


VTVT Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 83 35 0 26 17
Y / Y Investment Growth 136.72 % 8715.04 % -98.44 % 50.39 % 102.12 %
Net Income in Millions -31 -23 -26 -25 -18
Y / Y Net Income Growth - - - - -
Annual Return On Investment -37.33 % -64.55 % -6507.77 % -98.21 % -104.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VTVT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VTVT's Competitors
Subscribers only: Roi for Vtv Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for VTVT's Customers

Other Ratios
VTVT's Roa VTVT's Inventory Turnover Ratio VTVT's Growth Rates VTVT's Dividend Statistics
VTVT's Profitability Ratios VTVT's Asset Turnover Ratio VTVT's Dividend Growth
VTVT's Roe VTVT's Valuation Ratios VTVT's Financial Strength Ratios VTVT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:22:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.